AGIOS PHARMACEUTICALS

Lobbying for AGIOS PHARMACEUTICALS · Pharmacy, Medicare/Medicaid, Health Issues

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $70,000.00 expenses · posted Apr 17, 2026

Lobbying activity 3

Health Issues

Sickle Cell Policy Biotech Innovation

Medical/Disease Research/Clinical Labs

Biotech Innovation

Medicare/Medicaid

Medicaid Reform

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.